Artificial intelligence for anti-VEGF management in neovascular age-related macular degeneration: from predictive models toward clinical decision agents

Neovascular age-related macular degeneration remains one of the leading causes of irreversible central vision loss in older adults and commonly requires long-term, repeated intravitreal anti-vascular endothelial growth factor therapy. Although anti-VEGF treatment has substantially improved visual outcomes, real-world management is still limited by undertreatment, overtreatment, poor adherence, irregular follow-up, and persistent uncertainty regarding retreatment timing and interval extension. In this setting, artificial intelligence (AI) has rapidly evolved from image recognition toward clinically relevant prediction and decision support. The objective of this narrative review is to examine how current AI literature supports anti-VEGF management in neovascular age-related macular degeneration, where the strongest evidence currently exists, and where claims regarding decision agents remain premature. Deep learning models can now detect and quantify key optical coherence tomography biomarkers, including intraretinal fluid, subretinal fluid, pigment epithelial detachment, hyperreflective foci, and ellipsoid zone disruption. When combined with structured clinical variables and longitudinal follow-up data, machine learning and generative models have shown promise in predicting treatment response, recurrence, persistent activity, injection burden, and tolerated treatment intervals. However, most published studies remain retrospective, single-center, and prediction-focused, with limited external validation and little direct evidence for clinically deployable closed-loop decision systems. In this narrative review, we synthesize the literature across four linked domains: image interpretation, biomarker quantification, prediction of treatment-related outcomes, and agent-enabling technologies such as home monitoring and language-model-assisted decision support. We further distinguish established evidence from future-oriented concepts, discuss methodological limitations including heterogeneity of endpoints and limited reproducibility, and outline cautious directions for translation.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-13
DOI
https://doi.org/10.3389/fmed.2026.1981549
Primary Topic
Retinal Imaging and Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Artificial intelligence for anti-VEGF management in neovascular age-related macular degeneration: from predictive models toward clinical decision agents

Qi Dai, Lingyan Wu, Yi Zhang, Jiayuan Wang et al.
3 links
Frontiers in Medicine
Retinal Imaging and Analysis
article

Artificial intelligence for anti-VEGF management in neovascular age-related macular degeneration: from predictive models toward clinical decision agents

Qi Dai, Lingyan Wu, Yi Zhang, Jiayuan Wang, Zhiyi Hu, Xixi Zhang, Shanping Zhao
article en

Abstract

Neovascular age-related macular degeneration remains one of the leading causes of irreversible central vision loss in older adults and commonly requires long-term, repeated intravitreal anti-vascular endothelial growth factor therapy. Although anti-VEGF treatment has substantially improved visual outcomes, real-world management is still limited by undertreatment, overtreatment, poor adherence, irregular follow-up, and persistent uncertainty regarding retreatment timing and interval extension. In this setting, artificial intelligence (AI) has rapidly evolved from image recognition toward clinically relevant prediction and decision support. The objective of this narrative review is to examine how current AI literature supports anti-VEGF management in neovascular age-related macular degeneration, where the strongest evidence currently exists, and where claims regarding decision agents remain premature. Deep learning models can now detect and quantify key optical coherence tomography biomarkers, including intraretinal fluid, subretinal fluid, pigment epithelial detachment, hyperreflective foci, and ellipsoid zone disruption. When combined with structured clinical variables and longitudinal follow-up data, machine learning and generative models have shown promise in predicting treatment response, recurrence, persistent activity, injection burden, and tolerated treatment intervals. However, most published studies remain retrospective, single-center, and prediction-focused, with limited external validation and little direct evidence for clinically deployable closed-loop decision systems. In this narrative review, we synthesize the literature across four linked domains: image interpretation, biomarker quantification, prediction of treatment-related outcomes, and agent-enabling technologies such as home monitoring and language-model-assisted decision support. We further distinguish established evidence from future-oriented concepts, discuss methodological limitations including heterogeneity of endpoints and limited reproducibility, and outline cautious directions for translation.

Frontiers in MedicineVol. 13
Wenzhou Medical University (CN), Hangzhou Hospital of Traditional Chinese Medicine (CN)
Good health and well-being
Retinal Imaging and Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon